Media Inquiry / Request Form

This Media Inquiry Form is intended for use by members of the press / media only.

Use this form to submit requests to tour The Peak Dispensary’s operations, schedule an interview with company executives, film/photograph company facilities, or any other media-related requests.


Business / Partnership Inquiry Form

This Business Inquiry Form is intended for use by OMMA-licensed cannabis businesses only.

Use this form to submit business or partnership inquiries to The Peak Dispensary’s management team.


Franchising Inquiry Form

This Franchising Inquiry Form is intended for use by those interested in opening a franchised location of The Peak Dispensary.

Use this form to request additional information about The Peak Franchising.


New Jersey’s medical cannabis program sees increase in PTSD patients

More than 450 people suffering from post-traumatic stress disorder have enrolled in New Jersey’s medical marijuana program (MMJ) since mid-September, when Gov. Chris Christie agreed to add Post-Traumatic Stress Disorder (PTSD) to the list of treatable conditions.

The PTSD enrollees amount to about 4% of the 10,800 MMJ patients who legally buy medical cannabis from one of New Jersey’s five dispensaries, reported. The increase adds further momentum to New Jersey’s medical cannabis program, which has had to overcome numerous obstacles.

According to a state health department spokeswoman, 466 people who said they suffer from PTSD have qualified for the medical cannabis program since Christie’s decision.

The state health department’s medical advisory board has said it would consider requests from dozens of people to add other qualifying conditions for MMJ. The requested conditions include different causes of chronic pain, osteoarthritis, lupus and Lyme disease.

Chronic pain, in particular, could provide a big shot in the arm to New Jersey’s MMJ program by boosting the state’s patient pool and, potentially, sales.

New Jersey’s MMJ program has been hampered by a governor who, until recently, has shown little enthusiasm for medical cannabis. Moreover, the industry has been dogged by a dearth of doctors willing to be certified to recommend medical cannabis.